Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Trial of Recombinant Hepatitis E Vaccine

This study is ongoing, but not recruiting participants.
Xiamen Innovax Biotech Co., Ltd
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
National Institute of Diagnostics and Vaccine Development in infectious disease
Jiangsu Provincial Center for Disease Control and Prevention
Information provided by (Responsible Party):
Jun Zhang, Xiamen University Identifier:
First received: November 13, 2009
Last updated: January 3, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by Identifier (NCT Number):